ERM protein moesin is phosphorylated by advanced glycation end products and modulates endothelial permeability

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 297, Issue 1, 2009, Pages

  Guo, Xiaohua ^a   Wang, Lingjun ^a   Chen, Bo ^a   Li, Qiang ^a   Wang, Jiping ^a   Zhao, Ming ^a   Wu, Wei ^a   Zhu, Ping ^a   Huang, Xuliang ^a   Huang, Qiaobing ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Ezrin radixin moesin; Mitogen activated protein kinase; Receptor for advanced glycation end products; Rho kinase; Vascular permeability

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ACTIN; ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; EZRIN; F ACTIN; MITOGEN ACTIVATED PROTEIN KINASE P38; MOESIN; RADIXIN; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SMALL INTERFERING RNA; THREONINE;

ARTICLE; BLOOD VESSEL PERMEABILITY; CELL FUNCTION; CELL IMMORTALIZATION; CELL STRUCTURE; CONTROLLED STUDY; ENDOTHELIUM; ENDOTHELIUM CELL; ENZYME ACTIVATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MICROANGIOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

ADENOVIRIDAE; ANIMALS; BLOTTING, WESTERN; CAPILLARY PERMEABILITY; CELLS, CULTURED; COMPUTER SIMULATION; CYTOSKELETON; ENDOTHELIUM, VASCULAR; FLUORESCENT DYES; GENETIC VECTORS; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MICE; MICROFILAMENT PROTEINS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RHO-ASSOCIATED KINASES; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 67650079692     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00196.2009     Document Type: Article

References (42)

1. Ashwell JD. The many paths to p38 mitogen-activated protein kinase activation in the immune system. Nat Rev Immunol 6: 532-540, 2006.
2. Bardwell AJ, Frankson E, Bardwell L. Selectivity of docking sites in MAPK kinases. J Biol Chem. In press.
3. Basta G, Lazzerini G, Massaro M, Simoncini T, Tanganelli P, Fu C, Kislinger T, Stern DM, Schmidt AM, De Caterina R. Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses. Circulation 105: 816-822, 2002.
4. Berryman M, Franck Z, Bretscher A. Ezrin is concentrated in the apical microvilli of a wide variety of epithelial cells whereas moesin is found primarily in endothelial cells. J Cell Sci 105: 1025-1043, 1993.
5. Bogatcheva NV, Adyshev D, Mambetsariev B, Moldobaeva N, Verin AD. Involvement of microtubules, p38, and Rho kinases pathway in 2-methoxyestradiol-induced lung vascular barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 292: L487-L499, 2007.
6. Boutros T, Chevet E, Metrakos P. Mitogen-activated protein (MAP) kinase/MAP kinase phosphatase regulation: roles in cell growth, death, and cancer. Pharmacol Rev 60: 261-310, 2008.
7. Bretscher A, Edwards K, Fehon RG. ERM proteins and merlin: integrators at the cell cortex. Nat Rev Mol Cell Biol 3: 586-599, 2002.
8. Csortos C, Czikora I, Bogatcheva NV, Adyshev DM, Poirier C, Olah G, Verin AD. TIMAP is a positive regulator of pulmonary endothelial barrier function. Am J Physiol Lung Cell Mol Physiol 295: L440-L450, 2008.
9. Fiévet B, Louvard D, Arpin M. ERM proteins in epithelial cell organization and functions. Biochim Biophys Acta 1773: 653-660, 2007.
10. Forbes JM, Yee LT, Thallas V, Lassila M, Candido R, Jandeleit-Dahm KA, Thomas MC, Burns WC, Deemer EK, Thorpe SR, Cooper ME, Allen TJ. Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis. Diabetes 53: 1813-1823, 2004.
11. Gao X, Zhang H, Schmidt AM, Zhang C. AGE/RAGE produces endothelial dysfunction in coronary arterioles in type 2 diabetic mice. Am J Physiol Heart Circ Physiol 295: H491-H498, 2008.
12. Grande MT, López-Novoa JM. Therapeutical relevance of MAP-kinase inhibitors in renal diseases: current knowledge and future clinical perspectives. Curr Med Chem 15: 2054-2070, 2008.
13. Guo XH, Huang QB, Chen B, Wang ShY, Hou FF, Fu N. [Mechanism of advanced glycation end products-induced hyperpermeability in endothelial cells]. Acta Physiol Sino 57: 205-210, 2005.
14. Hébert M, Potin S, Sebbagh M, Bertoglio J, Bréard J, Hamelin J. Rho-ROCK-dependent ezrin-radixin-moesin phosphorylation regulates Fas-mediated apoptosis in Jurkat cells. J Immunol 181: 5963-5973, 2008.
15. Hou FF, Boyce J, Chertow GM, Kay J, Owen WF Jr. Aminoguanidine inhibits advanced glycation end products formation on β2-microglobulin. J Am Soc Nephrol 9: 277-283, 1998.
16. 2-Microglobulin modified with advanced glycation end products delays monocyte apoptosis. Kidney Int 59: 990-1002, 2001.
17. Ivetic A, Ridley AJ. Ezrin/radixin/moesin proteins and Rho GTPase signaling in leucocytes. Immunology 112: 165-176, 2004.
18. Koss M, Pfeiffer GR 2nd, Wang Y, Thomas ST, Yerukhimovich M, Gaarde WA, Doerschuk CM, Wang Q. Ezrin/radixin/moesin proteins are phosphorylated by TNF-alpha and modulate permeability increases in human pulmonary microvascular endothelial cells. J Immunol 176: 1218-1227, 2006.
19. Lan M, Kojima T, Murata M, Osanai M, Takano K, Chiba H, Sawada N. Phosphorylation of ezrin enhances microvillus length via a p38 MAP-kinase pathway in an immortalized mouse hepatic cell line. Exp Cell Res 312: 111-120, 2006.
20. Lee JH, Katakai T, Hara T, Gonda H, Sugai M, Shimizu A. Roles of p-ERM and Rho-ROCK signaling in lymphocyte polarity and uropod formation. J Cell Biol 167: 327-337, 2004.
21. Mangeat P, Roy C, Martin M. ERM proteins in cell adhesion and membrane dynamics. Trends Cell Biol 9: 187-192, 1999.
22. Marinissen MJ, Chiariello M, Gutkind JS. Regulation of gene expression by the small GTPase Rho through the ERK6 (p38 gamma) MAP kinase pathway. Genes Dev 15: 535-553, 2001.
23. Matsui T, Maeda M, Doi Y, Yonemura S, Amano M, Kaibuchi K, Tsukita S, Tsukita S. Rho-kinase phosphorylates COOH-terminal threonines of ezrin/radixin/moesin (ERM) proteins and regulates their head-to-tail association. J Cell Biol 140: 647-657, 1998.
24. New L, Jiang Y, Zhao M. PRAK, a novel protein kinase regulated by the p38 MAP kinase. EMBO J 17: 3372-3384, 1998.
25. Niggli V, Rossy JR. Ezrin/radixin/moesin: versatile controllers of signaling molecules and of the cortical skeleton. Int J Biochem Cell Biol 40: 344-349, 2008.
26. Origlia N, Righi M, Capsoni S, Cattaneo A, Fang F, Stern DM, Chen JX, Schmidt AM, Arancio O, Yan SD, Domenici L. Receptor for advanced glycation end product-dependent activation of p38 mitogen-activated protein kinase contributes to amyloid-beta-mediated cortical synaptic dysfunction. J Neurosci 28: 3521-3530, 2008.
27. Peppa J, Uribarri J, Vlassara H. Glucose, advanced glycation end products, and diabetes complications: what is new and what works. Clin Diabetes 21: 186-187, 2003.
28. Rahman S, Rahman T, Ismail AA, Rashid AR. Diabetes-associated macrovasculopathy: pathophysiology and pathogenesis. Diabetes Obes Metab 9: 767-780, 2007.
29. Shiue H, Musch MW, Wang Y, Chang EB, Turner JR. Akt2 phosphorylates ezrin to trigger NHE3 translocation and activation. J Biol Chem 280: 1688-1695, 2005.
30. Stein GH, St Clair JA. Human microvascular endothelial cells: coordinate induction of morphologic differentiation and twofold extension of life span. In Vitro Cell Dev Biol 24:381-387, 1998.
31. Talmor Y, Golan E, Benchetrit S, Bernheim J, Klein O, Green J, Rashid G. Calcitriol blunts the deleterious impact of advanced glycation end products on endothelial cells. Am J Physiol Renal Physiol 294: F1059-F1064, 2008.
32. Tan KC, Shiu SW, Chow WS, Leng L, Bucala R, Betteridge DJ. Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes. Diabetologia 49: 2756-2762, 2006.
33. Thomalley PJ. Cell activation by glycated proteins. AGE receptor, receptor recognition factors and functional classification of AGEs. Cell Mol Biol 44: 1013-1023, 1998.
34. Tinsley JH, Wu MH, Ma W, Taulman AC, Yuan SY. Activated neutrophils induce hyperpermeability and phosphorylation of adherens junction proteins in coronary venular endothelial cells. J Biol Chem 274: 24930-24934, 1999.
35. Vlassara H, Uribarri J, Cai W, Striker G. Advanced glycation end product homeostasis: exogenous oxidants and innate defenses. Ann NY Acad Sci 1126: 46-52, 2008.
36. Wang JP, Guo XH, Wang LJ, Li Q, Chen B, Wu W, Huang XL, Huang QB. [Effects of Rho/ROCK signal pathway on AGEs-induced morphological and functional changes in human dermal microvascular endothelial cells]. Sheng Li Xue Bao 61: 132-138, 2009.
37. Wang X, McGowan CH, Zhao M, He L, Downey JS, Fearns C, Wang Y, Huang S, Han J. Involvement of the MKK6-p38gamma cascade in gamma-radiation- induced cell cycle arrest. Mol Cel Biol 20: 4543-4552, 2000.
38. Wang ZH, Guo XH, Liu XL, Li Q, Wang JP, Wang LJ, Huang QB. The morphological changes of vascular endothelial cadherin in human umbilical vein endothelial cells induced by advanced glycation end products. Chin J Arterioscler 16: 505-509, 2008.
39. Yamagishi S, Nakamura K, Imaizumi T. Advanced glycation end products (AGEs) and diabetic vascular complications. Curr Diabetes Rev 1: 93-106, 2005.
40. Yoon YW, Kang TS, Lee BK, Chang W, Hwang KC, Rhee JH, Min PK, Hong BK, Rim SJ, Kwon HM. Pathobiological role of advanced glycation endproducts via mitogen-activated protein kinase dependent pathway in the diabetic vasculopathy. Exp Mol Med 40: 398-406, 2008.
41. +-glucose cotransport. Proc Natl Acad Sci USA 101: 9485-9490, 2004.
42. Zhu P, Tang L, Zhao SC, Lu X, Hou FF, Fu N. Preparation of monoclonal antibodies against different epitopes at the extracellular domain of the human receptor for advanced glycation end product. Di Yi Jun Yi Da Xue Xue Bao 24: 129-132, 2004.